
- The forced resignation of FDA vaccine regulator Peter Marks has, in part, sparked anxiety in Big Pharma investors, as shares in Moderna and Novavax slide. Marks’ departure comes amid a sweeping overhaul of the Department of Health and Human Services, helmed by vaccine skeptic Robert F. Kennedy Jr.
Key personnel changes within federal public health agencies have appeared to shake investor confidence in vaccine makers. Shares of Moderna and Novavax plunged Monday following the announcement Friday that key Food and Drug Administration official Peter Marks was stepping down from his position.